LBF20406CV16: Difference between revisions
(New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR8013 |LipidMaps=LMFA03120013 |SysName=Methyl- (5-cis,7-trans) -7- [ 4R-bromo-2- [cis-2-octenyl] -5-oxo-3-cyclopente...) |
No edit summary |
||
Line 6: | Line 6: | ||
|LipidBank=XPR8013 | |LipidBank=XPR8013 | ||
|LipidMaps=LMFA03120013 | |LipidMaps=LMFA03120013 | ||
|SysName=Methyl- (5- | |SysName=Methyl- (cis-5,trans-7) -7- [ 4R-bromo-2- (cis-2-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid | ||
|Common Name=&&Bromovulone I&&Methyl- (5Z,7E) -7- [ 4R-bromo-2- [( | |Common Name=&&Bromovulone I&&Methyl- (5Z,7E) -7- [ 4R-bromo-2- [ (2Z-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid&& | ||
|Optical=[ alpha ]_D +6.0°(C 0.05, MeOH)(Yamada Yasuji) | |Optical=[ alpha ]_D +6.0°(C 0.05, MeOH)(Yamada Yasuji) | ||
|Solubility=Bromovulone I is soluble in MeOH, EtOH, CHCl_3 , or hexane. | |Solubility=Bromovulone I is soluble in MeOH, EtOH, CHCl_3 , or hexane. |
Latest revision as of 06:04, 21 October 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR8013 |
LipidMaps | LMFA03120013 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20406CV16 |
Bromovulone I | |
---|---|
Structural Information | |
Methyl- (cis-5,trans-7) -7- [ 4R-bromo-2- (cis-2-octenyl) -5-oxo-3-cyclopentenylidene ] -5-heptenoic acid | |
| |
Formula | C21H29BrO4 |
Exact Mass | 424.12492201599997 |
Average Mass | 425.35655999999994 |
SMILES | C(CC=CC[C@](O)(C(=CC=CCCCC(OC)=O)1)C=C(C1=O)Br)CCC |
Physicochemical Information | |
[ α ]D +6.0°(C 0.05, MeOH)(Yamada Yasuji) | |
Bromovulone I is soluble in MeOH, EtOH, CHCl3, or hexane. | |
Bromovulone I was isolated from Japanese soft coral, Stolonifer Clavularia viridis Quoy and Gaimard. Iguchi_K et al. | |
Bromovulone I showed the strong antiproliferative and cytotoxic activities in himan promyelocytic leukemia (HL-60) ((IC_{50} 0.025 mu g/ml, cytotoxic effect >0.4 mu g/ml). Honda_A et al. Honda_A et al. Iguchi_K et al. | |
Spectral Information | |
Mass Spectra | EIMS m/z 424 and 426 (1:1) IguchiKet al. |
UV Spectra | λ EtOH max 247 nm( ε 12000),312 nm( ε 12000) IguchiKet al. |
IR Spectra | ν max(CHCl3)3300,1730, 1700, and 1630cm-1 IguchiKet al. |
NMR Spectra | 1H-NMR(400MHz,CDCl3) δ ppm0.89(3H,t,J=7.2Hz),1.30(6H,m),1.80(2H,quint.,J=7.4Hz),1.98(2H,brq,J=7.0Hz),2.36(2H,t,J=7.4Hz),2.42(2H,m),2.66(1H,brdd,J=7.8,14.9Hz),2.81(1H,brdd,J=7.6,14.9Hz),3.69(3H,s),5.22(1H,brtd,J=7.8,11.0Hz),5.55(1H,brtd,J=7.0,11.0Hz),6.11(1H,brtd,J=7.3,10.9Hz),6.77(1H,brdd,J=10.9,12.6Hz),7.35(1H,d,J=12.6Hz),7.43(1H,d,J=0.5Hz). IguchiKet al. |
Other Spectra | CD λ ext(EtOH)( Δ ε )nm 235(+5.6),260(-3.0),360(+1.2). IguchiKet al. |
Chromatograms |
Reported Metabolites, References | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|